Pierre Cremieux, a Managing Principal of Analysis Group, has a broad range of expertise in health economics, antitrust, statistics, and labor economics. He has consulted to numerous clients in the United States and Canada and testified in bench and jury trials, arbitrations, and administrative proceedings.
Dr. Cremieux has served as an expert and supported other experts in both litigation and non-litigation matters on antitrust issues, generic product entry, product liability and mass tort, analysis of clinical trials, and general commercial claims as well as a variety of labor related matters. He has assessed the evaluation of damages on a class wide basis in some of the largest class actions matters in recent years.
His scientific research in antitrust economics, class certification, health economics, and statistics has been published in numerous peer-reviewed journals including the George Mason Law Review, the American Bar Association Economics Committee Newsletter, the Review of Economics and Statistics, the Journal of Health Economics, Industrial and Labor Relations Review, the Journal of Clinical Oncology, and the American Journal of Managed Care. Dr. Cremieux’s research has been cited in leading media outlets including the Wall Street Journal and Forbes.
Dr. Cremieux has frequently presented at leading legal, health care, and economics seminars on topics such as antitrust, class certification, health economics and statistics in both the United States and Canada. He has also been invited to teach courses on economics, statistics and health care at various schools including McGill University, Boston University, and Harvard Medical School.
Prior to joining Analysis Group in 1997, Dr. Cremieux spent five years as a professor at the University du Québec à Montréal, where he still serves as an adjunct professor.